Drugs / Hawthorn
Hawthorn
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03663465 | Jan → Dec 2013 | schizophrenia | Calo Psychiatric Center | Completed | No outcome recorded |
| — | NCT00006330 | — | heart disorder | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hawthorn | “A Chinese herb, Hawthorn, is widely used for the treatment of dyslipidemia.” NCT03663465 ↗ |
| Known as | Crataegus oxyacantha | “Hawthorn (Crataegus oxyacantha) is a natural product that is popular in European and American herbal medicine practice.” NCT00006330 ↗ |
| Known as | Crataegus special extract WS1442 | “hawthorn (Crataegus special extract WS1442, Schwabe Co.) 450 mg twice daily or placebo” NCT00006330 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Hawthorn (Crataegus oxyacantha) is a natural product that is popular in European and American herbal medicine practice.” NCT00006330 ↗ |